Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

The Chi-PCOSQ is effective for assessing health-related quality of life in Chinese women with PCOS.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The revised Chinese Symptom Checklist-90 is more reliable and valid for psychological assessments.

Healthier hair and scalp improve mental wellbeing.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

In 2020, a new online survey was made to help identify Polycystic ovary syndrome (PCOS) in women, but it needs some improvements for better understanding and accuracy.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

The study created a 27-item measure to assess the impact of skin diseases.

Both EQ-5D-5L and SF-6DV2 are valid for measuring health but can't be used interchangeably.

WAA-QOL measures impact of hair loss on women's well-being.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

The Spanish version of the WAA-QoL questionnaire is reliable and valid for assessing quality of life in women with hair loss.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.